0

Liver Disease Collection
 81-100 of 955 Articles
Editorials |  7 November 2000
Methylene Blue and Cirrhosis: Pathophysiologic Insights, Therapeutic Dilemmas
Michael B. Fallon, MD
Ann Intern Med. 2000;133(9):738-740. doi:10.7326/0003-4819-133-9-200011070-00016
Articles |  7 November 2000
Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C: A Cost-Effectiveness Analysis
John B. Wong, MD; Raymond S. Koff, MD
Ann Intern Med. 2000;133(9):665-675. doi:10.7326/0003-4819-133-9-200011070-00008
Brief Communications |  7 November 2000
Methylene Blue Improves the Hepatopulmonary Syndrome
Peter Schenk, MD; Christian Madl, MD; Shahrzad Rezaie-Majd, MD; et al.
Ann Intern Med. 2000;133(9):701-706. doi:10.7326/0003-4819-133-9-200011070-00012
Articles |  5 September 2000
The Effect of HFE Genotypes on Measurements of Iron Overload in Patients Attending a Health Appraisal Clinic
Ernest Beutler, MD; Vincent Felitti, MD; Terri Gelbart, BS; et al.
Ann Intern Med. 2000;133(5):329-337. doi:10.7326/0003-4819-133-5-200009050-00008
Articles |  15 August 2000
Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes
Elif Arioglu, MD; Jennifer Duncan-Morin, RN; Nancy Sebring, RD; et al.
Ann Intern Med. 2000;133(4):263-274. doi:10.7326/0003-4819-133-4-200008150-00009
Brief Communications |  1 August 2000 FREE
Lactic Acidosis and Hepatic Steatosis Associated with Use of Stavudine: Report of Four Cases
Kirk D. Miller, MD; Miriam Cameron, MD; Lauren V. Wood, MD; et al.
Ann Intern Med. 2000;133(3):192-196. doi:10.7326/0003-4819-133-3-200008010-00010
Reviews |  2 May 2000
Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millennium
Arshad H. Malik, MD; William M. Lee, MD
Ann Intern Med. 2000;132(9):723-731. doi:10.7326/0003-4819-132-9-200005020-00007
Articles |  4 April 2000
Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy
Yasushi Shiratori, MD; Fumio Imazeki, MD; Mitsuhiko Moriyama, MD; et al.
Ann Intern Med. 2000;132(7):517-524. doi:10.7326/0003-4819-132-7-200004040-00002
Articles |  4 April 2000
Prevalence of Liver Disease and Contributing Factors in Patients Receiving Home Parenteral Nutrition for Permanent Intestinal Failure
Maryan Cavicchi, MD; Philippe Beau, MD; Pascal Crenn, MD; et al.
Ann Intern Med. 2000;132(7):525-532. doi:10.7326/0003-4819-132-7-200004040-00003
Articles |  18 January 2000
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Stefano Bellentani, MD, PhD; Gioconda Saccoccio, MD; Flora Masutti, MD; et al.
Ann Intern Med. 2000;132(2):112-117. doi:10.7326/0003-4819-132-2-200001180-00004
Brief Communications |  18 January 2000
Hepatic Failure in a Patient Taking Rosiglitazone
Lisa M. Forman, MD; David A. Simmons, MD; Robert H. Diamond, MD
Ann Intern Med. 2000;132(2):118-121. doi:10.7326/0003-4819-132-2-200001180-00005
Brief Communications |  18 January 2000
Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case Report
Jameela Al-Salman, MD; Heider Arjomand, MD; David G. Kemp, MD; et al.
Ann Intern Med. 2000;132(2):121-124. doi:10.7326/0003-4819-132-2-200001180-00006
Brief Communications |  16 November 1999
Influence of the Vitamin D Receptor Gene Polymorphism on Bone Loss in Men after Liver Transplantation
Jordi Guardiola, MD; Xavier Xiol, MD; Richard Sallie, MD, FRACP; et al.
Ann Intern Med. 1999;131(10):752-755. doi:10.7326/0003-4819-131-10-199911160-00006
Articles |  16 November 1999
Prophylactic Fluconazole in Liver Transplant Recipients: A Randomized, Double-Blind, Placebo-Controlled Trial
Drew J. Winston, MD; Anita Pakrasi, RN; Ronald W. Busuttil, MD, PhD
Ann Intern Med. 1999;131(10):729-737. doi:10.7326/0003-4819-131-10-199911160-00003
Brief Communications |  19 October 1999
Partial-Liver Transplantation To Treat Familial Amyloid Polyneuropathy: Follow-up of 11 Patients
Yo-ichi Takei, MD; Shu-ichi Ikeda, MD; Yasuhiko Hashikura, MD; et al.
Ann Intern Med. 1999;131(8):592-595. doi:10.7326/0003-4819-131-8-199910190-00008
Articles |  3 August 1999
Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan
Haruhiko Yoshida, MD; Yasushi Shiratori, MD; Mitsuhiko Moriyama, MD; et al.
Ann Intern Med. 1999;131(3):174-181. doi:10.7326/0003-4819-131-3-199908030-00003
Articles |  15 June 1999
HFE Genotype in Patients with Hemochromatosis and Other Liver Diseases
Bruce R. Bacon, MD; John K. Olynyk, MD; Elizabeth M. Brunt, MD; et al.
Ann Intern Med. 1999;130(12):953-962. doi:10.7326/0003-4819-130-12-199906150-00002
Brief Communications |  16 February 1999
Nefazodone-Induced Liver Failure: Report of Three Cases
Jaime Aranda-Michel, MD; Alison Koehler, MD; Pablo A. Bejarano, MD; et al.
Ann Intern Med. 1999;130(4_Part_1):285-288. doi:10.7326/0003-4819-130-4-199902160-00013
Currents |  15 December 1998
Solid Organ Transplantation. 1: Many Problems, New Solutions
Paul Kefalides, MD
Ann Intern Med. 1998;129(12):1093-1095. doi:10.7326/0003-4819-129-12-199812150-00049
Diagnosis and Management |  1 December 1998
Diagnosis of Hemochromatosis
Lawrie W. Powell, MD; D. Keith George, MD; Sharon M. McDonnell, MD; et al.
Ann Intern Med. 1998;129(11_Part_2):925-931. doi:10.7326/0003-4819-129-11_Part_2-199812011-00002
Advertisement

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)